Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biotherapy”

332 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 332 results

Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Testing effectiveness (Phase 2)WithdrawnNCT00004040
What this trial is testing

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)WithdrawnNCT05379322
What this trial is testing

The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Abu Dhabi Stem Cells Center
Testing effectiveness (Phase 2)UnknownNCT03188172
What this trial is testing

MUK Nine b: OPTIMUM Treatment Protocol

Who this might be right for
Multiple Myeloma
University of Leeds 95
Testing effectiveness (Phase 2)Study completedNCT00006292
What this trial is testing

Infliximab for the Treatment of Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT06788340
What this trial is testing

MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Odense University Hospital 166
Testing effectiveness (Phase 2)Study completedNCT00003153
What this trial is testing

Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group 22
Post-approval studies (Phase 4)Study completedNCT02983981
What this trial is testing

Topical Psoriasis Study for Patients Receiving Biologic Therapy

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 20
Not applicableLooking for participantsNCT03915262
What this trial is testing

Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease

Who this might be right for
Crohn Disease
Hospices Civils de Lyon 50
Post-approval studies (Phase 4)Study completedNCT03573323
What this trial is testing

Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 1,027
Not applicableUnknownNCT05767814
What this trial is testing

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies.

Who this might be right for
Psoriatic ArthritisRheumatoid Arthritis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 135
Early research (Phase 1)Not Yet RecruitingNCT07562815
What this trial is testing

Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors

Who this might be right for
Cancer
West China Hospital 9
Not applicableUnknownNCT04665141
What this trial is testing

Similarities and Differences of Biological Therapies for Severe Asthma.

Who this might be right for
Asthma
Clinica Universidad de Navarra, Universidad de Navarra 600
Post-approval studies (Phase 4)Not Yet RecruitingNCT06801353
What this trial is testing

A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)Biological TherapyBiomarkers
Beijing Tongren Hospital 90
Not applicableUnknownNCT04365205
What this trial is testing

Effect of Benralizumab on Airway Remodeling in Asthma

Who this might be right for
Asthma
University Hospital, Bordeaux 60
Not applicableUnknownNCT04089774
What this trial is testing

Benefit of Adapted Physical Activity for Patients Suffering From Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Hospital St. Joseph, Marseille, France 60
Not applicableStudy completedNCT02593006
What this trial is testing

Start Time Optimization of Biologics in Polyarticular JIA

Who this might be right for
Polyarticular Juvenile Rheumatoid ArthritisArthritis, Juvenile Idiopathic
Hackensack Meridian Health 400
Early research (Phase 1)UnknownNCT00002616
What this trial is testing

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Illinois at Chicago 36
Testing effectiveness (Phase 2)Study completedNCT00005948
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Next Page